Performance of the SD Bioline rapid diagnostic test as a good alternative to the detection of human African trypanosomiasis in Cameroon

Submitted: 6 March 2019
Accepted: 25 April 2022
Published: 11 October 2022
Abstract Views: 136
PDF: 80
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Background. Case detection is essential for the management of human African trypanosomiasis (HAT), which is caused by Trypanosoma brucei gambiense. Prior to parasitological confirmation, routine screening using the card agglutination test for trypanosomiasis (CATT) is essential. Recently, individual rapid diagnostic tests (RDTs) for the serodiagnosis of HAT have been developed. Objective. The purpose of this study was to evaluate the contribution of SD Bioline HAT to the serological screening of human African trypanosomiasis in Cameroonian foci.
Methods. Between June 2014 and January 2015, blood samples were collected during surveys in the foci of Campo, Yokadouma, and Fontem. The sensitivity (Se) and specificity (Sp) of SD Bioline HAT were determined using the CATT as the gold standard for the detection of specific antibodies against Trypanosoma brucei gambiense.
Results. A total of 88 samples were tested: 59.1% (n=52) in Campo, 31.8% (n=28) in Yokadouma, and 9.1% (n=8) in Fontem. There were 61.4% (n=54) males and 38.4% (n=34) females, and the average age was 35.4 19.0 years. In probed foci, the overall seroprevalence was 11.4% (95% confidence interval: 6.3-19.7) with the CATT method and 18.2% (95% confidence interval: 11.5-27.2%) with the SD Bioline HAT RDT method. The SD Bioline HAT’s Se and Sp were 80.0% and 89.7%, respectively.
Conclusions. This study demonstrated that the overall performance of the SD Bioline HAT was comparable to that of the CATT, with high specificity in the serological detection of HAT.

CDC - African Trypanosomiasis. Available from:

Blum JA, Neumayr AL, Hatz CF. Human African trypanosomiasis in endemic populations and travellers. Eur J Clin Microbiol Infect Dis 2012;905–13. Available from: DOI:

Stitch A, Abel PM, Krishna S. Human African trypanosomiasis. British Medical Journal 2002; 203–6. Available from: /bmj.325.7357.203 DOI:

Louis FJ, Buscher P, Lejon V. Diagnosis of human African trypanosomiasis in 2001. Med Trop. 2001;61. Available from:

Kennedy PGE. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol. 2006;36:505–12. DOI:

WHO. Trypanosomiasis, human African (sleeping sickness). World Health Organization. 2021. Available from:

Franco JR, Cecchi G, Priotto G, et al. Monitoring the elimination of human African trypanosomiasis. PLoS Negl Trop Dis. 2018;12. DOI:

Franco JR, Simarro PP, Diarra A, Jannin JG. Epidemiology of human African trypanosomiasis. Clin Epidemiol. 2014;6:257. Available from: DOI:

CDC - African Trypanosomiasis. Diagnosis. 2019;4–5. Available from:

Magnus E, Vervoort T, Van Meirvenne N. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b. gambiense trypanosomiasis. Ann Soc Belg Med Trop 1978;58:169–76.

Lejon V, Jacobs J, Simarro PP. Elimination of sleeping sickness hindered by difficult diagnosis. Bull World Health Organ. 2013;91:718. Available from: DOI:

Jamonneau V, Camara O, Ilboudo H, et al. Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa. PLoS Negl Trop Dis. 2015;9:e0003480. Available from: DOI:

Bessell PR, Lumbala C, Lutumba P, et al. Costeffectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo. PLoS One. 2018;13:e0204335. DOI:

Kanté ST, Melachio T, Ofon E, et al. Detection of wolbachia and different trypanosome species in Glossina palpalis palpalis populations from three sleeping sickness foci of southern Cameroon. Parasites and Vectors. 2018;11. DOI:

Chappuis F, Stivanello E, Adams K,et al. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in Southern Sudan. Am J Trop Med Hyg 2004;71:313–7. DOI:

Simo G, Mbida JAM, Eyenga VEO, et al. Challenges towards the elimination of Human African Trypanosomiasis in the sleeping sickness focus of Campo in southern Cameroon . Parasites and Vectors. Parasit Vectors 2014;7:374. DOI:

Njiokou F, Nimpaye H, Simo G, et al. Domestic animals as potential reservoir hosts of Trypanosoma brucei gambiense in sleeping sickness foci in Cameroon. Parasite. 2010;1761–6. Available from: DOI:

Status of human African trypanosomiasis in the Nola-Salo-Bilolo in the Central African Republic in 2005 - PubMed. Available from:

Chappuis F, Loutan L, Simarro P, et al. Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev. 2005;18:133–46. DOI:

Inojosa WO, Augusto I, Bisoffi Z, et al. Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies. BMJ Br Med J. 2006;332:1479. Available from: DOI:

Garcia A, Jamonneau V, Magnus E, et al. Follow-up of card agglutination trypanosomiasis test (CATT) positive but apparently aparasitaemic individuals in Côte d’Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health 2000;5:786–93. Available from: DOI:

Sternberg JM, Gierliński M, Biéler S, et al. Evaluation of the diagnostic accuracy of prototype rapid tests for human african trypanosomiasis. PLoS Negl Trop Dis 2014;8:e3373. Available from: DOI:

Bisser S, Lumbala C, Nguertoum E, et al. Sensitivity and specificity of a prototype rapid diagnostic test for the detection of trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study. PLoS Negl Trop Dis 2016;10:e0004608. DOI:

Deutou Wondeu, A. L., Okoko, A., Djeunang Dongho, G. B., Doll, C., Bahebegue, S., Mpeli Mpeli, U. S., Ninko, C. C., Montesano, C., Dologuele, N. F., & Awono-Ambene, H. P. (2022). Performance of the SD Bioline rapid diagnostic test as a good alternative to the detection of human African trypanosomiasis in Cameroon. Journal of Public Health in Africa, 13(3).


Download data is not yet available.